<scp>XBB</scp>.1.5 neutralizing antibodies upon bivalent <scp>COVID</scp>‐19 vaccination are similar to <scp>XBB</scp> but lower than <scp>BQ</scp>.1.1-Reference-Cited by-同舟云学术

XBB.1.5 neutralizing antibodies upon bivalent COVID‐19 vaccination are similar to XBB but lower than BQ.1.1

Published:2023-03-07 Issue:5 Volume:98 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Devasundaram Santhi¹^ORCID,Terpos Evangelos²^ORCID,Rosati Margherita¹^ORCID,Ntanasis‐Stathopoulos Ioannis²^ORCID,Bear Jenifer¹^ORCID,Burns Robert¹,Skourti Stamatia²,Malandrakis Panagiotis²^ORCID,Trougakos Ioannis P.³^ORCID,Dimopoulos Meletios‐Athanasios²^ORCID,Pavlakis George N.⁴^ORCID,Felber Barbara K.¹^ORCID

Affiliation:

1. Human Pathogenesis Retrovirus Section, Vaccine Branch Center for Cancer Research, National Cancer Institute Frederick Maryland USA

2. Department of Clinical Therapeutics, School of Medicine National and Kapodistrian University of Athens Athens Greece

3. Department of Cell Biology and Biophysics, Faculty of Biology National and Kapodistrian University of Athens Athens Greece

4. Vaccine Branch, Center for Cancer Research, National Cancer Institute Frederick Maryland USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26887

Reference10 articles.

1. Emergence and geographic dominance of Omicron subvariants XBB/XBB.1.5 and BF.7 – the public health challenges

2. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants

3. Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage

4. Age‐dependent and gender‐dependent antibody responses against SARS‐CoV ‐2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine

5. Greek cohort.2022https://cov-spectrum.org/explore/Greece/AllSamples/Y2022/variants?nextcladePangoLineage=ba.4*&

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in People Living with HIV (PLWH);Vaccines;2024-07-17

2. The development of a rapid, high-throughput neutralization assay using a SARS-CoV-2 reporter;Journal of Virological Methods;2024-05

3. Diminished neutralizing activity against the XBB1.5 strain in 55.9% of individuals post 6 months COVID-19 mRNA booster vaccination: insights from a pseudovirus assay on 1,353 participants in the Fukushima vaccination community survey, Japan;Frontiers in Immunology;2024-03-18

4. Targeting SIRT1 by Scopoletin to Inhibit XBB.1.5 COVID-19 Life Cycle;Current Reviews in Clinical and Experimental Pharmacology;2024-03-01

5. Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge;Nature Communications;2024-02-20